Redmile Group, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Neurogene Inc. Common Stock, $0.000001 par value (NGNE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
Neurogene Inc. Common Stock, $0.000001 par value
Symbol
NGNE
Shares outstanding
14,947,131 shares
Disclosed Ownership
1,479,766 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 20:01:27 UTC
Date of event
31 Dec 2024
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 9.9% 1,479,766 0 1,479,766 /s/ Jeremy C. Green Managing Member
Jeremy C. Green 9.9% 1,479,766 0 1,479,766 /s/ Jeremy C. Green Jeremy C. Green
Redmile Biopharma Investments I, L.P. 5.4% 812,033 0 812,033 /s/ Jeremy C. Green Managing Member of Redmile Group, LLC, managing member of Redmile Biopharma Investments I (GP), LLC, GP of Redmile Biopharma Investments I, L.P.